Your session is about to expire
← Back to Search
MDMA-AT for Post-Traumatic Stress Disorder (MDMA Trial)
MDMA Trial Summary
This trial is the first of its kind to test the effects of MDMA-assisted therapy on military veterans who have both Alcohol Use Disorder and Post-Traumatic Stress Disorder. The treatment involves therapy sessions combined
MDMA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMDMA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 1 & 2 trial • 12 Patients • NCT02876172MDMA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any current opportunities for potential participants to enroll in this trial?
"According to the details available on clinicaltrials.gov, this current trial is actively seeking volunteers. The initial posting of this research study was on February 6th, 2024, with the most recent update being on February 7th, 2024."
What is the aggregate count of individuals currently enrolled in this clinical investigation?
"Indeed, the information on clinicaltrials.gov shows that this study is actively seeking individuals to participate. The trial was initially listed on February 6th, 2024, with the most recent update made on February 7th, 2024. It aims to enroll a total of 18 participants from one designated site."
What are the safety implications of utilizing MDMA-assisted therapy for individuals undergoing treatment?
"In view of this being a Phase 2 clinical trial, our team at Power gauges the safety rating of MDMA-AT to be 2 due to existing data supporting its safety profile but lacking evidence on efficacy."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger